Technology | June 08, 2010

Stent Graft Treats Larger Thoracic Aortic Aneurysms

June 8, 2010 – A 45 mm diameter stent graft to treat thoracic aortic aneurysms (TAA) has been cleared by the U.S. Food and Drug Administration (FDA). W. L. Gore & Associates said its new, larger version of the Gore Tag Thoracic Endoprosthesis is for the treatment of aneurysms of the descending thoracic aorta.

The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 to 42 mm.

“The availability of the 45 mm Gore Tag Device will provide physicians treating thoracic aneurysms with more options,” explained Michel Makaroun, M.D., chief of the division of vascular surgery and professor of surgery at the University of Pittsburgh Medical Center (UPMC). Makaroun acted as the national principal investigator for the device clinical study.

The Gore Tag is available in 10, 15 and 20 cm lengths. In addition, the devices are delivered on a modified device delivery catheter that is designed for enhanced trackability and deliverability. The modified device delivery catheter uses simple, single-step deployment. The sheathless delivery catheter provides flexibility for navigating tortuous anatomy and low deployment forces.

The Gore Tag device was first approved by the FDA in March 2005. It internally relines the thoracic aorta and isolates the diseased segment from blood circulation. The device is comprised of an ePTFE (Gore-Tex) graft with a self-expanding nitinol support structure to combine both device flexibility and material durability. The device is inserted via a catheter delivery technique through a small incision in the patient’s groin.

For more information: www.goremedical.com

Related Content

Endologix Reports Positive One-Year Results From the Ovation LUCY Study
News | Stent Grafts | July 16, 2018
Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for...
FDA Committee Votes in Favor of Incraft AAA Stent Graft System
News | Stent Grafts | June 13, 2018
Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has received a favorable...
First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
FDA Concerned About Increase in stent graft Endovascular Type III Leaks
News | Stent Grafts | October 09, 2017
October 9, 2017 — The U.S.
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts | July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
News | Stent Grafts | April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts | January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts | January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts | January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
News | Stent Grafts | December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
Overlay Init